Panacea Biotec Limited (NSE:PANACEABIO)
India flag India · Delayed Price · Currency is INR
436.35
-7.45 (-1.68%)
Apr 9, 2025, 3:30 PM IST

Panacea Biotec Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2015 - 2019
Revenue
5,6305,5924,5996,6126,2485,441
Upgrade
Revenue Growth (YoY)
2.06%21.57%-30.44%5.83%14.84%19.13%
Upgrade
Cost of Revenue
1,9722,3012,5272,6222,0461,568
Upgrade
Gross Profit
3,6583,2902,0733,9904,2023,873
Upgrade
Selling, General & Admin
1,7701,6431,5172,0501,7741,649
Upgrade
Other Operating Expenses
1,7851,6951,1921,9871,5441,362
Upgrade
Operating Expenses
3,9083,7053,1004,4743,7743,443
Upgrade
Operating Income
-249.69-414.69-1,027-484.18427.33429.26
Upgrade
Interest Expense
-27.53-26.73-38.03-1,798-1,847-1,731
Upgrade
Interest & Investment Income
83.8183.81120.6233.9432.6847.92
Upgrade
Earnings From Equity Investments
----0.773.3
Upgrade
Currency Exchange Gain (Loss)
36.2336.2320.775.8-6.88-8.39
Upgrade
Other Non Operating Income (Expenses)
-38.28-9.08-6.34-10.02-6.45-8.7
Upgrade
EBT Excluding Unusual Items
-195.46-330.46-930.37-2,253-1,399-1,268
Upgrade
Gain (Loss) on Sale of Investments
33.6733.6714.470.01--
Upgrade
Gain (Loss) on Sale of Assets
-2.64-2.6452.930.07-0.38-290.52
Upgrade
Asset Writedown
-46.14-46.14-29.94-15.75-42.63-
Upgrade
Other Unusual Items
110.24360.341,02116,762--153.97
Upgrade
Pretax Income
-100.3314.77128.0514,494-1,442-1,712
Upgrade
Income Tax Expense
-13.0829.82465.53,71019.57166.4
Upgrade
Earnings From Continuing Operations
-87.25-15.05-337.4510,783-1,462-1,879
Upgrade
Earnings From Discontinued Operations
-----14.55-64.36
Upgrade
Net Income to Company
-87.25-15.05-337.4510,783-1,477-1,943
Upgrade
Minority Interest in Earnings
8.123.325.08-0.19-0.380.29
Upgrade
Net Income
-79.13-11.73-332.3710,783-1,477-1,943
Upgrade
Net Income to Common
-79.13-11.73-332.3710,783-1,477-1,943
Upgrade
Shares Outstanding (Basic)
586161616161
Upgrade
Shares Outstanding (Diluted)
586161616161
Upgrade
EPS (Basic)
-1.36-0.19-5.43176.05-24.11-31.72
Upgrade
EPS (Diluted)
-1.36-0.19-5.43176.05-24.11-31.72
Upgrade
Free Cash Flow
--778.18-4,634-1,210848.87-371.38
Upgrade
Free Cash Flow Per Share
--12.71-75.66-19.7513.86-6.06
Upgrade
Gross Margin
64.97%58.85%45.07%60.35%67.25%71.18%
Upgrade
Operating Margin
-4.44%-7.42%-22.34%-7.32%6.84%7.89%
Upgrade
Profit Margin
-1.41%-0.21%-7.23%163.08%-23.64%-35.71%
Upgrade
Free Cash Flow Margin
--13.92%-100.75%-18.29%13.59%-6.83%
Upgrade
EBITDA
99.33-47.58-636.16-56.28872.65861.45
Upgrade
EBITDA Margin
1.76%-0.85%-13.83%-0.85%13.97%15.83%
Upgrade
D&A For EBITDA
349.02367.11391.23427.9445.32432.19
Upgrade
EBIT
-249.69-414.69-1,027-484.18427.33429.26
Upgrade
EBIT Margin
-4.44%-7.42%-22.34%-7.32%6.84%7.89%
Upgrade
Effective Tax Rate
-201.90%363.53%25.60%--
Upgrade
Revenue as Reported
5,8595,8505,1166,7226,3485,737
Upgrade
Advertising Expenses
-113.04218.21220.05183.74209.78
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.